Breast Cancer Study on Atorvastatin for Cardiotoxicity Prevention Receives $4.4 Million Funding
Breast Cancer News, News
Cardiotoxicity is a common concern in cancer patients receiving chemotherapeutic agents, as it can lead to serious cardiovascular complications such as heart failure, myocardial ischemia, hypertension, thromboembolism, and arrhythmias. These conditions ... Read more